Zoetis Inc (ZTS)
165.02
+1.53
(+0.94%)
USD |
NYSE |
Jan 08, 16:00
164.99
-0.03
(-0.02%)
After-Hours: 20:00
Zoetis Research and Development Expense (Annual): 614.00M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vertex Pharmaceuticals Inc | 3.69B |
| Alnylam Pharmaceuticals Inc | 1.004B |
| Biomarin Pharmaceutical Inc | 746.77M |
| Corcept Therapeutics Inc | 184.35M |
| Plus Therapeutics Inc | 9.69M |